Evidence map›Paper›PMID 20717113›Full record

ArticleBritish journal of cancer2010

SV40 associated miRNAs are not detectable in mesotheliomas.

G V Gee, M L Stanifer, B C Christensen, W J Atwood, D Ugolini, S Bonassi, M B Resnick, H H Nelson, C J Marsit, K T Kelsey

Abstract readValidation Study
In one paragraph

Article in British journal of cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

G V GeeDepartment of Pathology and Laboratory Medicine, Brown University, Box G-E-5, Providence, RI 02912, USA.
M L Stanifer
B C Christensen
W J Atwood
D Ugolini
S Bonassi
M B Resnick
H H Nelson
C J Marsit
K T Kelsey

Funding

WNT SIGNALING IN HEPATOCELLULAR CARCINOMAP20RR015578 · NCRR · BROWN UNIVERSITY · PI THOMPSON, WILLIAM ALBERT · 2000 to 2009
$22.8M
TRAINING IN ENVIRONMENTAL PATHOLOGYT32ES007272 · NIEHS · BROWN UNIVERSITY · PI ZHITKOVICH, ANATOLY · 1992 to 2021
$7.5M
The Epidemiology of Molecular Alterations in MesotheliomaR01CA126939 · NCI · BROWN UNIVERSITY · PI KELSEY, KARL TIMOTHY · 2008 to 2012
$2.4M
NCI NIH HHS R01 CA126939NCRR NIH HHS P20 RR015578NIEHS NIH HHS 2 T32 ES 007272-16NIEHS NIH HHS T32 ES007272
6 · The paper itself

Abstract

backgroundSimian virus-40 (SV40) is a DNA tumour virus that was introduced into the human population with contaminated poliovirus vaccine, and its role in mesothelioma is widely debated. PCR based testing has been called into question, as false positives can be because of cross-reactivity with related viruses, or to laboratory contamination. The Institute of Medicine has recommended the development of more sensitive and specific tests to resolve this controversy.

methodsWe have characterized highly sensitive RT-PCR based assays that are specific for SV40-encoded microRNAs (miRNAs), as an alternative to current testing methods.

resultsUsing this sensitive and specific detection method, we were unable to identify SV40 miRNA expression in human malignant pleural mesothelioma (MM) samples.

conclusionOur work indicates that SV40 miRNAs are not likely to contribute to mesothelioma tumourogenesis, but highlights the value of this approach when compared with the relatively unspecific current testing methods.

Indexed as

BiopsyHumansMesotheliomaMicroRNAsSimian virus 40MicroRNAs

Identifiers

PMID20717113
PMCPMC2966630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.